View in EDS

RWD88 Real-World Economic Burden Pre- and Post-Progression to Metastatic Castration-Resistant Prostate Cancer (mCRPC) and after First-Line mCRPC Therapy Initiation.

Saved in:
Bibliographic Details
Title: RWD88 Real-World Economic Burden Pre- and Post-Progression to Metastatic Castration-Resistant Prostate Cancer (mCRPC) and after First-Line mCRPC Therapy Initiation.
Authors: Kaye, D.R1 (AUTHOR), Khilfeh, I.2 (AUTHOR), Muser, E.2 (AUTHOR), Morrison, L.3 (AUTHOR), Holiday, C.3 (AUTHOR), Kinkead, F.3 (AUTHOR), Lefebvre, P.3 (AUTHOR), Pilon, D.3 (AUTHOR), George, D.1 (AUTHOR)
Source: Value in Health. 2023 Supplement, Vol. 26 Issue 6, pS377-S377. 1p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2023.03.2117